Keyphrases
Trypanosome
100%
MRNA Turnover
100%
Enzymatic Activity
40%
MRNA Stability
40%
Trypanosomatids
40%
MRNA Decay
40%
Decapping Enzymes
40%
African Trypanosomiasis
40%
South America
20%
Major Diseases
20%
Human Host
20%
Transcriptional Regulation
20%
Chagas Disease
20%
Disability-adjusted Life Years
20%
Middle East
20%
Life Cycle Stages
20%
Disease Burden
20%
Cell-free System
20%
Experiment Planning
20%
Cutaneous Leishmaniasis
20%
Treatment Costs
20%
Tsetse Fly
20%
Human Disease
20%
Mucocutaneous Leishmaniasis
20%
Trypanosomiasis
20%
Leishmaniasis
20%
Trypanosoma Brucei
20%
Expression Pattern
20%
Nuclease
20%
Therapeutic Approaches
20%
Visceral Leishmaniasis
20%
Metabolic Pathway
20%
Central America
20%
Sleeping Sickness
20%
Insect Host
20%
Deadenylase
20%
Steady State
20%
World Health Organization
20%
MRNA Expression
20%
Developing Countries
20%
Indian Subcontinent
20%
Immunology and Microbiology
Trypanosoma
100%
Life Cycle
60%
Trypanosomatid
40%
Enzyme Activity
40%
mRNA Stability
40%
Disease Burden
20%
Tsetse Fly
20%
Cell Free System
20%
Cutaneous Leishmaniasis
20%
Visceral Leishmaniasis
20%
Chagas Disease
20%
Disability-Adjusted Life Year
20%
Steady State
20%
Metabolism
20%
Trypanosoma Brucei
20%
Leishmaniasis
20%
Nuclease
20%
Medicine and Dentistry
Messenger RNA
100%
African Trypanosomiasis
42%
mRNA Stability
28%
Enzyme Activity
28%
Life-Cycle Form
28%
Trypanosomatid
28%
Diseases
28%
Metabolism
14%
Tsetse Fly
14%
Nuclease
14%
Life Cycle
14%
Disease Burden
14%
Steady State
14%
Leishmaniasis
14%
Disability Adjusted Life Years
14%
Visceral Leishmaniasis
14%
Cutaneous Leishmaniasis
14%
Chagas Disease
14%
Infection
14%
Trypanosoma Brucei
14%
Trypanosomiasis
14%
Health Care Cost
14%
Bite
14%